Cash Flow from Operation (CFO) to Debt Ratio Analysis of Immuneering Corp - Deep Dive


Cash Flow from Operation (CFO) to Debt Ratio of IMRX
Dec-23
-0.163
Very Poor CFO to Debt
Dec-22
-116.45
Very Poor CFO to Debt
Growth
99.86
%
CFO to Debt Analysis of Immuneering Corp
Cashflow to Debt Ratio of Immuneering Corp with value of -0.163 shows the company has low cash flow to pay off their debts.
CFO to Debt of IMRX rose handsomely by 99.86 % this year.
CFO to Debt with value of 0 was highest in Year Dec-19 in last Five Years.
CFO to Debt with value of -191.57 was lowest in Year Dec-20 in last Five Years.
Latest CFO to Debt with value of -0.163 is Greater than Average CFO to Debt of -84.15 in last five years.
Other CFO to Debt Related Info of IMRX that may interest you.
Immuneering Corp Overview
CodePricePrevious PricePrice ChangeSector
IMRX1.391.38 0.725 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Cash Flow from Operation (CFO) to Debt Ratio
Cash Flow from Operation (CFO) to Debt Ratio indicates how much time it will take for the company to meet its debt obligations by its cash flow from operations.   more ..
Cash Flow from Operation (CFO) to Debt Ratio Formula

CFO to Debt Related Ratios
DebtToEBITDAShortTermDebtToEquityRatioPriceToCashFlowRatio

Tsr Stability Index
Mild Stability
FY - Historical Cash Flow from Operation (CFO) to Debt Ratio of Immuneering Corp
PeriodDec-23Dec-22Dec-21Dec-20Dec-19
CFO to Debt-0.163-116.45-112.58-191.570
Change99.86 %-3.44 %41.23 %
FY Chart of Cash Flow from Operation (CFO) to Debt Ratio of Immuneering Corp


Note : All Data Generated at the End of Trading Hours (EOD Data)